Next Article in Journal
Cystic Fluid Total Proteins, Low-Density Lipoprotein Cholesterol, Lipid Metabolites, and Lymphocytes: Worrisome Biomarkers for Intraductal Papillary Mucinous Neoplasms
Previous Article in Journal
RAS-Beppu Classification: A New Recurrence Risk Classification System Incorporating the Beppu Score and RAS Status for Colorectal Liver Metastases
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Measurement of Melanocytic Choroidal Lesions: Ultrasound Versus Ultrawide-Field Fundus Imaging System

by
Maria C. Baradad-Jurjo
*,
Daniel Lorenzo
,
Estel·la Rojas-Pineda
,
Laura Vigués-Jorba
,
Rahul Morwani
,
Lluís Arias
,
Pere Garcia-Bru
,
Estefania Cobos
,
Juan Francisco Santamaria
,
Carmen Antia Rodríguez-Fernández
and
Josep M. Caminal
Ophthalmology Department, Bellvitge University Hospital, Feixa Llarga Street, s/n, 08907 Hospitalet de Llobregat, Spain
*
Author to whom correspondence should be addressed.
Cancers 2025, 17(4), 642; https://doi.org/10.3390/cancers17040642
Submission received: 24 January 2025 / Revised: 9 February 2025 / Accepted: 11 February 2025 / Published: 14 February 2025
(This article belongs to the Section Cancer Causes, Screening and Diagnosis)

Simple Summary

Tumor size is an important factor in the diagnosis, treatment planning, follow-up and prognosis of melanocytic choroidal tumors. While ultrasonography is the most used technique for tumor measuring, new imaging techniques may also become a useful tool. The aim of our study was to assess the reliability of an ultrawide-field imaging system in measuring basal dimensions of choroidal tumors between observers and to compare this technique to conventional ophthalmic ultrasound. We found excellent concordance for interobserver and inter-technique agreement. Our findings suggest that, in some cases, ultrawide-field imaging could be used instead of ultrasonography for the measurement of basal diameters of melanocytic choroidal tumors. This technique is faster, more comfortable for the patient and less operator-dependent than conventional ultrasonography.

Abstract

Objectives: The aim of this study was to establish the concordance between conventional 20 Mhz ultrasonography and an ultrawide-field (UWF) imaging system (Optos® California) in the measurement of basal diameters of melanocytic choroidal tumors. Methods: A retrospective study comparing diagnostic tests was conducted in patients with untreated melanocytic choroidal lesions (either nevus or melanoma) who had undergone both UWF imaging and ultrasonography. Only cases with a clear visualization of tumor borders in both imaging modalities were included. Longitudinal and transversal base diameters of the melanocytic tumors were measured by 20 MHz US (one observer) and UWF fundus photography (two observers). Interobserver agreement was assessed for UWF imaging first to validate the technique. Then, UWF imaging measurements were compared with 20 MHz US results. Results: In total, 106 patient images were reviewed, of which 61 were excluded due to unclear visualization of tumor margins. We found excellent concordance (from ICC and defined Bland–Altman plots) for interobserver and inter-technique agreement in estimating basal diameters when using pseudocolor composite and red laser images by comparing them with 20 MHz US results. Conclusions: UWF fundus imaging, when complete visualization of the tumor margins is possible, could be as reliable as ultrasonography in the measurement of the basal diameters of choroidal melanocytic tumors.

1. Introduction

Melanocytic choroidal lesions are the most common intraocular tumors [1,2,3,4,5]. Several clinical studies have found that tumor size is a key factor in the diagnosis of, selection of treatment for, follow-up of and prognosis of (i.e., larger melanomas are associated with higher mortality rates) these patients [6,7,8]. Currently, most ophthalmologists base their diagnosis on clinical examination, including indirect funduscopy and retinography, and ultrasound, which is the current gold-standard technique for measuring tumors, especially their thickness, as well as for tumor inner reflectivity characterization [9].
Several new imaging techniques have emerged in recent years, many of which have proven useful to better characterize these lesions and complement ultrasonography. For instance, MRI is becoming more popular and may give a more accurate volume calculation, but it is expensive and less immediate since it is not available in our daily ophthalmology practice [10,11,12,13]. With regards to ophthalmologic complementary testing, optic coherence tomography (OCT) and wide-field fundus imaging have an important role in our everyday practice [14,15,16]. The advent of noncontact ultrawide-field imaging systems has enabled the capture of the posterior pole and peripheral retina up to 200° in a single image. One example of this new technology is Optos® (Optos, Marlborough, MA, USA), an ultrawide-field (UWF) scanning laser ophthalmoscope (SLO) that uses two laser wavelengths (red and green) to generate three different types of images: green laser view (green channel) images for the retina and its vasculature, red laser view (red channel) images for the choroid, and images with a combination of the two to digitally generate a pseudocolor realistic fundus image.
UWF SLO may prove to be a valuable tool for measuring basal tumor diameters, offering several advantages over ultrasonography such as being more comfortable for the patient and less time-consuming. However, it is necessary to consider that fundus imaging is a two-dimension representation of a three-dimensional structure obtained through the use of ellipsoidal mirrors. This results in some image distortion, especially in the peripheral retina, which can be magnified up to two times, and in the horizontal axis, which can appear stretched compared to the vertical axis [17]. Nevertheless, the new software version (ProView for Optos® California, https://www.optos.com/our-software-products, access date 13 September 2024) includes a change in the algorithm to correct for the peripheral distortion that could make measurements more accurate [18].
The aim of our study was to assess the reliability of Optos® California ultrawide-field (UWF) imaging in measuring basal dimensions of choroidal tumors between observers and to compare this technique to conventional standardized 20 MHz ophthalmic ultrasound (US).

2. Materials and Methods

2.1. Study Design and Eligibility Criteria

This was a retrospective study of data obtained from patients who underwent ophthalmological evaluation from January 2019 to January 2021 at the Ocular Oncology Unit of the Ophthalmology Department at Bellvitge University Hospital (Barcelona, Spain).
We included a consecutive series of patients diagnosed with untreated melanocytic choroidal lesions (either nevus or melanoma) that had undergone both UWF imaging and ultrasonography during the initial visit to our department. Patients that did not have the two imaging modalities performed on the same date and those without clear visualization of tumor borders in both imaging modalities were excluded. Patients excluded due to poor tumor visualization were classified in the following categories: peripheral tumors with partial visualization of the anterior margin, extensive exudative retinal detachment that blurred the visualization of the tumor, big tumors in which the apex covered the base partially, and tumors in which ultrasound was unable to provide an accurate assessment of the tumor size due to its low height.

2.2. Ultrasound Image Acquisition

All patients underwent a complete ophthalmologic ultrasound examination. In all cases, A- and B-scan images were obtained using a 20 Mhz US transducer (OTI-scan 2000, OTI Ophthalmic Technologies Inc.; North York, ON, Canada). Each examination included a longitudinal and transverse scan of the tumor. Calipers were used to measure the maximum transverse and longitudinal diameters on the B-scan image. All measurements were made by the same senior ophthalmology consultant (JMC).

2.3. Ultrawide Field Image Acquisition

For UWF imaging, using the Optos® California (Optos, Marlborough, MA, USA) pseudocolor composite, red laser and green laser photos were obtained on the same day as the ultrasound by a technician. Transverse and longitudinal diameter measurements were assessed retrospectively for purposes of the present study by one ophthalmologist (observer 1) and one ophthalmology resident (observer 2), both blinded to the other’s measurements (both for UWF imaging and ultrasound). The basal diameters on UWF imaging were measured according to standard topographic US reference diameters (Figure 1).

2.4. Statistical Analysis

The demographic and clinical characteristics of the sample were described as means ± standard deviation (minimum–maximum) for quantitative variables and as numbers (n) and percentages for categorical variables. In all continuous variables used for comparison, the normal distribution was assessed by the Shapiro–Wilk test.
The following analyses were conducted to determine agreement between the devices and the observers with regards to lesion basal diameters (longitudinal and transverse diameters): (1) Paired t-tests and Bland–Altman plots were used to assess interobserver agreement for lesion size measured by UWF imaging and agreement between measurements of the lesion dimensions made by UWF (observer 1) and 20 MHz US (2). The interobserver reliability of UWF image measurements and the inter-technique reliability between the use of UWF and 20 MHz US were assessed using the intraclass correlation coefficient (ICC). The agreement was classified as poor (<0.6), good (0.6 to 0.74), or excellent (≥0.75).
All analyses were conducted using Stata IC, v. 15.1 (StataCorp; College Station, TX, USA). A two-tailed p-value < 0.05 was considered statistically significant.

3. Results

Images of 106 patients were reviewed. The initial diagnosis was distributed as follows: choroidal nevi (n = 44; 41.5%) and choroidal melanoma (n = 62; 58.5%). Of the 106 patients primarily included, 61 patients (57.5%) were excluded (20 choroidal nevi, 32.8%; 41 choroidal melanoma, 67.2%). The main cause for exclusion was, in 43 cases (70%), incomplete visualization of the tumoral base in UWF pseudocolor imaging due to the following reasons: peripheral tumors with partial visualization of the anterior margin (23 patients, 38%); extensive exudative retinal detachment that blurred the visualization of the tumor (9 patients, 14%); big tumors in which the apex covered the base partially (5 patients, 8%). In the remaining patients who were excluded from the study (18 patients, 30%), ultrasound was unable to provide an accurate assessment of the tumor size due to its low height. Eventually, 45 cases (42.5%) were included in the comparison of the two diagnostic techniques. Table 1 summarizes the baseline demographic and clinical characteristics of the patients, including ultrasound mean measurement values.
Firstly, interobserver agreement in UWF imaging was assessed. Table 2 shows the mean lesion sizes obtained by each observer and paired t-test results. Paired t-tests revealed that measurements from the pseudocolor and red channel images for both diameters were not statistically different when measured by the two observers (p > 0.05). However, for the green channel images, both observers stated that in 20 cases, the tumor could not be measured and, when it was possible, the values were statistically different (p < 0.05). For this reason, green channel images were not compared further. Figure 2 shows Bland–Altman plots for interobserver agreement in pseudocolor and red channel UWF imaging. The mean difference was around zero (between −0.28 and −0.13) in all cases, and 95% of the measurements fell within the limits of agreement except for the longitudinal pseudocolor images, where 6.7% of the points of the longitudinal basal diameter measurements were located outside the 95% limits of agreement.
Inter-technique agreement was then evaluated. Again, no statistical differences were detected between US and both pseudocolor and red laser photographs, while statistically significant differences were found on paired t-tests for the green channel images and US measurements (Table 3). Bland–Altman plots for the agreement in lesion size parameters between UWF pseudocolor and red laser images and US are shown in Figure 3. Even though both techniques were found to be significantly equivalent, ultrasonography mean values tended to be slightly higher than UWF values.
Finally, the correlation (ICC) between measurements was assessed. The UWF SLO (pseudocolor composite and red channel) between two observers (reliability of measures between observers) and the correlation (ICC) between measurements made with UWF SLO versus 20 MHz US (reliability of measures between tests) by specific measurements were excellent for all measures (Table 4).

4. Discussion

Ultrasound is currently the most frequently used tool to objectively measure tumor size, monitor growth and plan for the treatment of melanocytic choroidal tumors. However, while it is the gold-standard technique for tumor thickness measurement, clinicians may use and combine different imaging methods for basal diameter measurement [9,19]. Basal diameters are an important parameter for both diagnostic and prognostic reasons [6,7,8], and although US has shown to be a reliable technique when performed by an experienced ocular oncologist, it has some remarkable disadvantages [20,21]. For instance, US requires a certain tumor height (at least 0.4 mm) to allow the clinician to identify the tumor during examination, so quantification of the size of these tumors needs alternative imaging techniques. Moreover, even in larger tumors, the flat portion in the peripheral part of the lesions cannot be accurately assessed with US. On the other hand, ultrasonography examination is a time-consuming procedure that must be performed by a highly skilled professional and, nevertheless, repeating the same exact scanning plane in successive evaluations is virtually impossible. Finally, it is well known that ultrasound tends to overestimate dimensions when compared to histopathologic measurements, as reported in the COMS study, with particularly poor agreement for basal diameters [22].
Fundus photography has always been an important tool for the documentation of tumor characteristics and changes during follow-up. Over the past decade, advances in technology have made it possible to progressively increase the field of view of different imaging systems, so that lesions located in the peripheral retina, which could not be imaged with traditional fundus photography, can now be visualized with these new devices [23]. Among other advantages, this type of examination is comfortable for the patient, as it often does not require mydriasis, is performed by a trained technician, and may be suitable for telemedicine. Regarding the assessment of basal tumor dimensions using UWF funduscopic images, the main advantage over ultrasound is the reproducibility of the examination and the ease of locating lesions and repeating measurements in the same plane in successive examinations as well as measuring the distance to important intraocular structures such as the fovea or the optic nerve head.
Nonetheless, the main drawback of assessing tumor basal dimensions using UWF funduscopic images arises from the fact that it is a representation of the curved surface of the retina displayed on a flat plane. Distortion of the peripheral retina results in variable magnification of the lesion size when it is located post-equatorially depending on eye characteristics, such as axial length, refraction or different lesion location, and the device used [24,25]. In order to minimize peripheral distortion, improvements in image processing software have been attempted. For the purpose of our study, we used the Optos® California device, which includes ProView (https://www.optos.com/our-software-products, access date 13 September 2024), upgraded software, which corrects the peripheral distortion and horizontal elongation found in its predecessor, the Optos® 200TX [18,26].
The aim of our study was to assess the reliability of the Optos® California UWF imaging system in measuring dimensions of choroidal melanocytic tumors between observers and to compare and correlate this technique with 20 MHz US.
We found an excellent ICC and defined Bland–Altman plots for interobserver and inter-technique agreement in estimating basal diameters when using pseudocolor composite and red laser images. However, when using green laser images, agreement was poor and, in many cases, measurement was not possible. As stated before, the green laser cannot penetrate below the retinal pigmented epithelium (RPE) and, thus, the image offers a good view of the retina and its vasculature but does not allow for visualization of the choroid. Although retinal changes are observed in many melanocytic choroidal tumors and they translate into alterations in the green channel images, these differ in each tumor and are not related to its size. On the other hand, the red laser has the ability to penetrate through the RPE and gives a clearer image of the choroidal tumor boundaries. Overall, this is consistent with the fact that agreement is good when using the red laser images or its pseudocolor composite, but it becomes unreliable when using the green channel. Although it did not give statistically different results in our study, the red channel should theoretically provide more accurate measurements than the pseudocolor composite since the latter could be influenced by retinal changes detected by the green laser.
A few studies have previously compared US and UWF imaging systems in the measurement of choroidal tumors [27,28,29]. Our findings align with those of previous studies, yet comparisons are challenging due to the use of different UWF imaging devices and the inclusion of participants with diverse characteristics, including those with choroidal tumors of varying histological origins. The study by Ayres et al. [29], which included melanocytic and non-melanocytic choroidal tumors measured by US and Optos® 200TX, concluded that US and UWF pseudocolor and red laser images were statistically equivalent. In another study, Wang et al. [30] used Clarus 500 with similar results. Although no statistical differences were found, both studies reported a tendency toward higher values for UWF imaging in comparison to US. In our study, however, we did not encounter such a tendency, and, in general, the US measurements were slightly higher than the UWF values. This is likely attributable to the aforementioned software upgrades that address peripheral magnification.
The main limitation in the use of UWF imaging in the measurement of the basal diameters of melanocytic choroidal lesions is the large number of cases with incomplete recognizable borders (57% in our study), mainly due to the partially visible anterior margin in peripheral tumors. In these cases, as well as in cases with any other cause of improper visualization of the tumor margins such as media opacity or exudative retinal detachment, ultrasonography continues to be essential. In contrast, in those tumors with a low height that cannot be located by US, UWF imaging has become a useful tool for both documentation and sizing.
The main limitation of this study is the relatively limited number of tumors evaluated, the large number of excluded cases, and the inherent limitations of it being a retrospective study. The main strength of the study is that this is the first to compare Optos® California and its improved software ProView to 20 MHz US to measure the basal diameters of melanocytic choroidal tumors, as well as the fact that it had a more homogeneous sample than previous studies that have included choroidal tumors of varying histological origins.

5. Conclusions

While ultrasonography is essential in the measurement of melanocytic choroidal tumors, our findings suggest that when complete visualization of the tumor is possible, UWF fundus imaging could be as reliable as ultrasonography in the measurement of the basal diameters. An important advantage of UWF imaging versus US is that it is less operator-dependent and more comfortable for the patient, which makes it a desirable characteristic for routine clinical use. However, while both techniques can be complimentary, ultrasonography cannot be replaced by UWF fundus imaging since it remains the gold-standard technique for tumor thickness measurement and it is the only option in cases where there is unclear visualization of the tumor margins or media opacity.

Author Contributions

Conceptualization, M.C.B.-J., E.R.-P., D.L. and J.M.C.; methodology, M.C.B.-J., D.L. and J.M.C.; validation, M.C.B.-J., D.L. and J.M.C.; formal analysis, M.C.B.-J., D.L. and J.M.C.; investigation, M.C.B.-J. and E.R.-P.; resources, M.C.B.-J.; data curation, M.C.B.-J. and E.R.-P.; writing—original draft preparation, M.C.B.-J.; writing—review and editing, M.C.B.-J., D.L. and J.M.C.; visualization, L.V.-J., R.M., L.A., E.C., P.G.-B., J.F.S. and C.A.R.-F.; supervision, J.M.C.; project administration, J.M.C. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

This study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board (or Ethics Committee) of Bellvitge University Hospital (protocol code ICPS023/20, 23 January 2023).

Informed Consent Statement

Patient consent was waived due to retrospective, observational evaluation of the anonymized data.

Data Availability Statement

The raw data supporting the conclusions of this article can be made available by the authors on request.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Ganley, J.P.; Comstock, G.W. Benign nevi and malignant melanomas of the choroid. Am. J. Ophthalmol. 1973, 76, 19–25. [Google Scholar] [CrossRef] [PubMed]
  2. Shields, C.L.; Furuta, M.; Mashayekhi, A.; Berman, E.L.; Zahler, J.D.; Hoberman, D.M.; Dinh, D.H.; Shields, J.A. Clinical spectrum of choroidal nevi based on age at presentation in 3422 consecutive eyes. Ophthalmology 2008, 115, 546–552.e2. [Google Scholar] [CrossRef] [PubMed]
  3. Shields, C.L.; Furuta, M.; Mashayekhi, A.; Berman, E.L.; Zahler, J.D.; Hoberman, D.M.; Dinh, D.H.; Shields, J.A. Visual acuity in 3422 consecutive eyes with choroidal nevus. Arch. Ophthalmol. 2007, 125, 1501–1507. [Google Scholar] [CrossRef]
  4. Singh, A.D.; Kalyani, P.; Topham, A. Estimating the risk of malignant transformation of a choroidal nevus. Ophthalmology 2005, 112, 1784–1789. [Google Scholar] [CrossRef]
  5. Sumich, P.; Mitchell, P.; Wang, J.J. Choroidal nevi in a white population: The Blue Mountains Eye Study. Arch. Ophthalmol. 1998, 116, 645–650. [Google Scholar] [CrossRef]
  6. Shields, C.L.; Sioufi, K.; Srinivasan, A.; Dinicola, M.; Masoomian, B.; Barna, L.E.; Bekerman, V.P.; Say, E.A.T.; Mashayekhi, A.; Emrich, J.; et al. Visual Outcome and Millimeter Incremental Risk of Metastasis in 1780 Patients with Small Choroidal Melanoma Managed by Plaque Radiotherapy. JAMA Ophthalmol. 2018, 136, 1325–1333. [Google Scholar] [CrossRef] [PubMed]
  7. Diener-West, M.; Reynolds, S.M.; Agugliaro, D.J.; Caldwell, R.; Cumming, K.; Earle, J.D.; Hawkins, B.S.; Hayman, J.A.; Jaiyesimi, I.; Jampol, L.M.; et al. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26. Arch. Ophthalmol. 2005, 123, 1639–1643. [Google Scholar] [CrossRef] [PubMed]
  8. Shields, C.L.; Dalvin, L.A.; Ancona-Lezama, D.; Yu, M.D.; Di Nicola, M.; Williams, B.K.; Lucio-Alvarez, J.A.; Ang, S.M.; Maloney, S.; Welch, R.J.; et al. Choroidal nevus imaging features in 3806 cases and risk factors for transformation into melanoma in 2355 cases. Retina 2019, 39, 1840–1851. [Google Scholar] [CrossRef] [PubMed]
  9. Kadakia, A.; Zhang, J.; Yao, X.; Zhou, Q.; Heiferman, M.J. Ultrasound in ocular oncology: Technical advances, clinical applications, and limitations. Exp. Biol. Med. 2023, 248, 371. [Google Scholar] [CrossRef] [PubMed]
  10. Furdova, A.; Furda, R.; Sramka, M.; Chorvath, M.; Rybar, J.; Vesely, P.; Valaskova, J.; Siska, V. Stereotactic irradiation on linear accelerator—Ultrasound versus MRI in choroidal melanoma volume calculation. BMC Ophthalmol. 2022, 22, 333. [Google Scholar] [CrossRef]
  11. Jaarsma-Coes, M.G.; Klaassen, L.; Marinkovic, M.; Luyten, G.P.M.; Vu, T.H.K.; Ferreira, T.A.; Beenakker, J.W.M. Magnetic Resonance Imaging in the Clinical Care for Uveal Melanoma Patients—A Systematic Review from an Ophthalmic Perspective. Cancers 2023, 15, 2995. [Google Scholar] [CrossRef]
  12. Fonk, L.G.; Ferreira, T.A.; Webb, A.G.; Luyten, G.P.M.; Beenakker, J.W.M. The Economic Value of MR-Imaging for Uveal Melanoma. Clin. Ophthalmol. 2020, 14, 1135. [Google Scholar] [CrossRef]
  13. Lee, C.H.; Lee, H.; Lee, S.M.; Choi, E.Y.; Lee, J.; Kim, M. Clinical and Multimodal Imaging Features of Choroidal Nevi in the Korean Population. J. Clin. Med. 2022, 11, 6666. [Google Scholar] [CrossRef] [PubMed]
  14. de França Martins, M.; Kiefer, K.; Kanecadan, L.A.A.; Garcia, P.N.; Belfort, R.N.; Allemann, N. Comparisons of choroidal nevus measurements obtained using 10- and 20-MHz ultrasound and spectral domain optical coherence tomography. Arq. Bras. Oftalmol. 2017, 80, 78–83. [Google Scholar] [CrossRef]
  15. Shah, S.U.; Kaliki, S.; Shields, C.L.; Ferenczy, S.R.; Harmon, S.A.; Shields, J.A. Enhanced depth imaging optical coherence tomography of choroidal nevus in 104 cases. Ophthalmology 2012, 119, 1066–1072. [Google Scholar] [CrossRef] [PubMed]
  16. Kaur, G.; Anthony, S.A. Multimodal imaging of suspicious choroidal neoplasms in a primary eye-care clinic. Clin. Exp. Optom. 2017, 100, 549–562. [Google Scholar] [CrossRef]
  17. Lee, J.; Sagong, M. Ultra-Widefield Retina Imaging: Principles of Technology and Clinical Applications. J. Retin. 2016, 1, 1–10. [Google Scholar] [CrossRef]
  18. Kato, Y.; Inoue, M.; Hirakata, A. Quantitative comparisons of ultra-widefield images of model eye obtained with Optos® 200Tx and Optos® California. BMC Ophthalmol. 2019, 19, 115. [Google Scholar] [CrossRef] [PubMed]
  19. Daniels, A.B.; Veverka, K.K.; Patel, S.N.; Sculley, L.; Munn, G.; Pulido, J.S. Computing uveal melanoma basal diameters: A comparative analysis of several novel techniques with improved accuracy. Int. J. Retin. Vitr. 2019, 5, 2. [Google Scholar] [CrossRef] [PubMed]
  20. Peyster, R.G.; Augsburger, J.J.; Shields, J.A.; Satchell, T.V.; Markoe, A.M.; Clarke, K.; Haskin, M.E. Choroidal melanoma: Comparison of CT, fundoscopy, and US. Radiology 1985, 156, 675–680. [Google Scholar] [CrossRef] [PubMed]
  21. Haritoglou, C.; Neubauer, A.S.; Herzum, H.; Freeman, W.R.; Mueller, A.J. Interobserver and intraobserver variability of measurements of uveal melanomas using standardised echography. Br. J. Ophthalmol. 2002, 86, 1390. [Google Scholar] [CrossRef] [PubMed]
  22. Diener-West, M.; Albert, D.M.; Byrne, S.F.; Davidorf, F.H.; Followill, D.; Green, R.L.; Hawkins, B.S.; Kaiser, P.K.; Robertson, D.M.; Straatsma, B.R. Comparison of clinical; echographic, and histopathological measurements from eyes with medium-sized choroidal melanoma in the Collaborative Ocular Melanoma Study: COMS report no. 21. Arch. Ophthalmol. 2003, 121, 1163–1171. [Google Scholar] [CrossRef]
  23. Callaway, N.F.; Mruthyunjaya, P. Widefield imaging of retinal and choroidal tumors. Int. J. Retin. Vitr. 2019, 5, 49. [Google Scholar] [CrossRef]
  24. Sagong, M.; Van Hemert, J.; De Koo, L.C.O.; Barnett, C.; Sadda, S.R. Assessment of accuracy and precision of quantification of ultra-widefield images. Ophthalmology 2015, 122, 864–866. [Google Scholar] [CrossRef]
  25. Croft, D.E.; Van Hemert, J.; Wykoff, C.C.; Clifton, D.; Verhoek, M.; Fleming, A.; Brown, D.M. Precise montaging and metric quantification of retinal surface area from ultra-widefield fundus photography and fluorescein angiography. Ophthalmic Surg. Lasers Imaging Retin. 2014, 45, 312–317. [Google Scholar] [CrossRef] [PubMed]
  26. Oishi, A.; Hidaka, J.; Yoshimura, N. Quantification of the image obtained with a wide-field scanning ophthalmoscope. Investig. Ophthalmol. Vis. Sci. 2014, 55, 2424–2431. [Google Scholar] [CrossRef] [PubMed]
  27. Kim, Y.; Hwang, T.S.; Choi, D.; Wilson, D.J. Comparison of digital fundus photographic and echographic measurements for maximal linear dimension from eyes with choroidal melanoma. Retina 2009, 29, 1321–1327. [Google Scholar] [CrossRef] [PubMed]
  28. Kernt, M.; Schaller, U.C.; Stumpf, C.; Ulbig, M.W.; Kampik, A.; Neubauer, A.S. Choroidal pigmented lesions imaged by ultra-wide-field scanning laser ophthalmoscopy with two laser wavelengths (Optomap). Clin. Ophthalmol. 2010, 4, 829–836. [Google Scholar] [CrossRef] [PubMed]
  29. Ayres, B.; Stacey, A.; Grant, J.; McClendon, T.; Demirci, H. Comparative study of clinical, ultrasonographic, conventional imaging, and ultra-wide-field fundus for measurements of the longest basal diameter of choroidal tumors. Ophthalmic Surg. Lasers Imaging Retin. 2017, 48, 459–464. [Google Scholar] [CrossRef]
  30. Wang, Q.; Yang, J.Y.; Wei, W.B.; Yang, Q. Comparative Study of Ultrasonography and Ultra-Widefield Fundus Photographs for Measurements of the Diameter of Choroidal and Retinal Tumors. Ophthalmol. Ther. 2023, 12, 3001. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Example of measurement of choroidal melanoma transversal diameter (blue line) by ultrasonography (a), ultrawide-field pseudocolor composite (b), red laser imaging (c) and green laser imaging (d). In this case, we found a difficulty in locating the border of the tumor in the images of the green channel with respect to those of the red channel and those taken using the pseudocolor composite.
Figure 1. Example of measurement of choroidal melanoma transversal diameter (blue line) by ultrasonography (a), ultrawide-field pseudocolor composite (b), red laser imaging (c) and green laser imaging (d). In this case, we found a difficulty in locating the border of the tumor in the images of the green channel with respect to those of the red channel and those taken using the pseudocolor composite.
Cancers 17 00642 g001
Figure 2. Bland—Altman plots for inter-observer agreement in tumor size parameters using utra-wide-field imaging. To aid interpretation, the same scale is used in all plots. LoA: limits of agreement.
Figure 2. Bland—Altman plots for inter-observer agreement in tumor size parameters using utra-wide-field imaging. To aid interpretation, the same scale is used in all plots. LoA: limits of agreement.
Cancers 17 00642 g002
Figure 3. Bland–Altman plots for the agreement in lesion size parameters between ultrawide-field imaging and 20 MHz ultrasonography. LoA: limits of agreement.
Figure 3. Bland–Altman plots for the agreement in lesion size parameters between ultrawide-field imaging and 20 MHz ultrasonography. LoA: limits of agreement.
Cancers 17 00642 g003
Table 1. Baseline features of included patients.
Table 1. Baseline features of included patients.
Demographic characteristics
Mean Age (Years)67 ± 12.6 (38 to 87)
Gender (Female/Male)27 (60%)/18 (40%)
Eye (Right/Left)25 (56%)/20 (44%)
Clinical characteristics
Best corrected visual acuity—decimal scale0.5 (Count Fingers to 1.0)
Diagnosis
Nevus24 (53%)
Melanoma21 (47%)
Pigmentation
Pigmented44 (98%)
Amelanotic1 (2%)
Subretinal fluid
Present24 (53%)
Absent21 (47%)
Tumor location
Posterior pole11 (24%)
Periphery34 (76%)
Ultrasound measurements
Height (mm)2.65 ± 1.51 (0.70 to 6.10)
Transversal diameter (mm)8.84 ± 2.91 (4 to 15)
Longitudinal diameter9.36 ± 2.90 (4 to 14.50)
Values represent mean ± standard deviation (minimum and maximum) value for quantitative variables, and n (percentage) for categorical variables.
Table 2. Mean values in mm and standard deviation (SD) for each diameter measured by the two observers in UWF fundus images, and paired t-test comparison results of the different measurements.
Table 2. Mean values in mm and standard deviation (SD) for each diameter measured by the two observers in UWF fundus images, and paired t-test comparison results of the different measurements.
Observer 1Observer 2p-Value
(Paired t-Test)
Transversal diameter—pseudocolor composite8.45 (2.86)8.64 (2.98)0.126 *
Longitudinal diameter—pseudocolor composite9.24 (2.90)9.39 (3.01)0.471 *
Transversal diameter—red channel8.38 (2.60)8.25 (2.87)0.491 *
Longitudinal diameter—red channel9.30 (2.86)9.21 (3.07)0.641 *
Transversal diameter—green channel7.11 (3.99)7.48 (3.87)0.038
Longitudinal diameter—green channel8.15 (4.13)8.42 (3.98)0.044
Non-statistically significant difference between the means (*).
Table 3. Paired t-test comparison results of the two measurement methods.
Table 3. Paired t-test comparison results of the two measurement methods.
Measurement TechniqueUltrasound
UWF TD—pseudocolor composite0.051 *
UWF LD—pseudocolor composite0.525 *
UWF TD—red channel0.063 *
UWF LD—red channel0.870 *
UWF TD—green channel0.000
UWF LD—green channel0.000
UWF: ultrawide field. TD: transversal diameter. LD: longitudinal diameter. * Non-statistically significant difference between the means.
Table 4. Intraclass correlation coefficient (95% confidence interval) between measurements made with UWF between two observers (reliability of measures between observers) and results of the ICC between measurements made with UWF versus 20 MHz US (reliability of measures between tests) by specific measurements.
Table 4. Intraclass correlation coefficient (95% confidence interval) between measurements made with UWF between two observers (reliability of measures between observers) and results of the ICC between measurements made with UWF versus 20 MHz US (reliability of measures between tests) by specific measurements.
ICC between measurements made with UWF between two observers
Transverse diameterLongitudinal diameter
Pseudocolor composite0.98 (0.96–0.98)0.94 (0.89–0.97)
Red channel0.95 (0.90–0.97)0.95 (0.90–0.97)
ICC between measurements made with UWF versus 20 MHz US
Transverse diameterLongitudinal diameter
Pseudocolor composite—US0.94 (0.89–0.97)0.95 (0.90–0.97)
Red channel—US0.95 (0.90–0.97)0.96 (0.93–0.98)
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Baradad-Jurjo, M.C.; Lorenzo, D.; Rojas-Pineda, E.; Vigués-Jorba, L.; Morwani, R.; Arias, L.; Garcia-Bru, P.; Cobos, E.; Santamaria, J.F.; Rodríguez-Fernández, C.A.; et al. Measurement of Melanocytic Choroidal Lesions: Ultrasound Versus Ultrawide-Field Fundus Imaging System. Cancers 2025, 17, 642. https://doi.org/10.3390/cancers17040642

AMA Style

Baradad-Jurjo MC, Lorenzo D, Rojas-Pineda E, Vigués-Jorba L, Morwani R, Arias L, Garcia-Bru P, Cobos E, Santamaria JF, Rodríguez-Fernández CA, et al. Measurement of Melanocytic Choroidal Lesions: Ultrasound Versus Ultrawide-Field Fundus Imaging System. Cancers. 2025; 17(4):642. https://doi.org/10.3390/cancers17040642

Chicago/Turabian Style

Baradad-Jurjo, Maria C., Daniel Lorenzo, Estel·la Rojas-Pineda, Laura Vigués-Jorba, Rahul Morwani, Lluís Arias, Pere Garcia-Bru, Estefania Cobos, Juan Francisco Santamaria, Carmen Antia Rodríguez-Fernández, and et al. 2025. "Measurement of Melanocytic Choroidal Lesions: Ultrasound Versus Ultrawide-Field Fundus Imaging System" Cancers 17, no. 4: 642. https://doi.org/10.3390/cancers17040642

APA Style

Baradad-Jurjo, M. C., Lorenzo, D., Rojas-Pineda, E., Vigués-Jorba, L., Morwani, R., Arias, L., Garcia-Bru, P., Cobos, E., Santamaria, J. F., Rodríguez-Fernández, C. A., & Caminal, J. M. (2025). Measurement of Melanocytic Choroidal Lesions: Ultrasound Versus Ultrawide-Field Fundus Imaging System. Cancers, 17(4), 642. https://doi.org/10.3390/cancers17040642

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop